Trending Now
LATEST ARTICLES
Can Pharma Be Funny About Serious Disease? Damon Wayans Is Testing the Line.
Healthcare advertising has spent decades trying to make serious diseases feel urgent. Genentech is experimenting with a different question: What if making people laugh...
AI Cut the Hours. Should Pharma Still Pay Agencies the Same Way?
AI can now turn work that once took days into work that takes hours. That creates an uncomfortable question for marketers: if production time...
A Bar Stool Started a Cancer Conversation. That’s the Point.
What if the best way to start a conversation about colorectal cancer was to make someone look twice at a bar stool?
That is the...
What Happens When Doctors—Not Marketers—Pick the Best Pharma Campaign?
Pharma marketing has no shortage of awards. Creative directors, strategists, brand leaders, agency executives, and industry juries routinely decide which campaigns represent the best...
The EHR Is Becoming Programmatic Media. Pharma Buyers Should Pay Attention.
For years, pharmaceutical marketers have treated point-of-care media as something adjacent to the broader digital advertising ecosystem.
Display, connected TV, online video, paid social, and...
“Health Equity” Disappeared From the Pitch Deck. Did the Marketing Strategy Actually Change?
“Health equity” is disappearing from some corporate conversations, but does that mean the work behind it is disappearing too? For pharmaceutical marketers, the answer...
Pharma Marketing Keeps Getting Smarter. Patients Still Want It to Feel Human.
Pharma marketing has never had more sophisticated tools. AI can accelerate content creation, predictive analytics can uncover audience signals, and omnichannel platforms can personalize...
FDA Wants to Speed Up Early Drug Development. Marketing May Be the Next Bottleneck.
The FDA wants early drug development to move faster. Now pharma companies may need to ask whether their commercial organizations can keep up.
On September...
Pharma Just Created Awards for Data and Point of Care. That Says More Than...
The 2026 Fierce Pharma Marketing Awards did something more interesting than name this year’s standout campaigns. They changed what counts as award-worthy pharma marketing.
For...
What If You Could See Nonadherence Coming Before the Patient Disappears?
What if pharmaceutical marketers could recognize the warning signs of therapy abandonment before a patient actually disengages? That possibility is moving closer with predictive...
